Company / Capital Returned to Shareholders per Share
Amneal Pharmaceuticals, Inc. Capital Returned to Shareholders per Share History
FY2017-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders per Share
$1.44
FY2020
5-year range
-
FY2017-FY2020
Trend
-51.2%
vs FY2019
Sector context
#21 of 51
Health Care
What the data says
At $1.44, Amneal Pharmaceuticals, Inc.'s capital returned to shareholders per share ranks #21 of 51 in the Health Care sector. Declined from $1.58 to $1.44 over the past 2 years.
Based on SEC 10-K filings.
1.44 in FY2020 with a 3-year CAGR of -98.4%.
Declined from $1.58 to $1.44 over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders per Share over time
Growth rates
- 3-Year CAGR
- -98.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#21 of 51 in Health CareTop 41% of 51This company $1.44 Sector average $2.74
▼
-47.4% below sector average
Key checks
Key Insights
- In FY2020, capital returned to shareholders per share decreased 51.2% year-over-year.
- Ranks #21 out of 51 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 1.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to Shareholders per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | $1.44 | -51.2% |
| FY2019 | $2.95 | +87.1% |
| FY2018 | $1.58 | -100.0% |
| FY2017 | $375265.00 | - |
| FY2016 | - | - |
As of FY2020 · SEC 10-K · Updated Jun 30, 2026